CatalystPit

RTSNRetension Pharmaceuticals, Inc.

RECENT NEWS
  • Retension Pharmaceuticals prices IPO at $12 per share
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS